Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
Aragon-Ching
Jeanny B
JB
Dahut
William L
WL
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D050071:Bone Density Conservation Agents; D004164:Diphosphonates